End-of-day quote
Taiwan S.E.
03:30:00 14/05/2024 am IST
|
5-day change
|
1st Jan Change
|
90.5
TWD
|
-0.33%
|
|
-1.95%
|
+2.38%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
5,895
|
6,907
|
7,918
|
8,130
|
10,019
|
13,757
|
Enterprise Value (EV)
1 |
3,581
|
4,957
|
5,076
|
5,121
|
7,599
|
11,793
|
P/E ratio
|
13.1
x
|
13.5
x
|
13.9
x
|
13.5
x
|
15.1
x
|
18.5
x
|
Yield
|
6.52%
|
6.12%
|
6.24%
|
6.08%
|
5.4%
|
4.3%
|
Capitalization / Revenue
|
0.93
x
|
1.07
x
|
1.19
x
|
1.24
x
|
1.39
x
|
1.67
x
|
EV / Revenue
|
0.56
x
|
0.77
x
|
0.76
x
|
0.78
x
|
1.06
x
|
1.43
x
|
EV / EBITDA
|
6.94
x
|
9.11
x
|
8.24
x
|
7.13
x
|
10.2
x
|
13.6
x
|
EV / FCF
|
-25.2
x
|
4
x
|
7.08
x
|
7.47
x
|
19.8
x
|
-139
x
|
FCF Yield
|
-3.96%
|
25%
|
14.1%
|
13.4%
|
5.06%
|
-0.72%
|
Price to Book
|
0.87
x
|
0.99
x
|
1.04
x
|
1.05
x
|
1.22
x
|
1.6
x
|
Nbr of stocks (in thousands)
|
1,41,284
|
1,41,284
|
1,55,617
|
1,55,617
|
1,55,617
|
1,55,617
|
Reference price
2 |
41.72
|
48.89
|
50.88
|
52.24
|
64.38
|
88.40
|
Announcement Date
|
29/03/19
|
26/03/20
|
26/03/21
|
21/03/22
|
23/03/23
|
14/03/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
6,345
|
6,457
|
6,675
|
6,573
|
7,187
|
8,233
|
EBITDA
1 |
515.7
|
544
|
616.3
|
717.7
|
741.4
|
866.1
|
EBIT
1 |
438.1
|
464
|
529.1
|
595
|
606.6
|
702.9
|
Operating Margin
|
6.9%
|
7.19%
|
7.93%
|
9.05%
|
8.44%
|
8.54%
|
Earnings before Tax (EBT)
1 |
648.5
|
746.8
|
829.4
|
873.7
|
963.7
|
1,144
|
Net income
1 |
451.6
|
514.8
|
571.7
|
607.1
|
667.5
|
746.6
|
Net margin
|
7.12%
|
7.97%
|
8.56%
|
9.24%
|
9.29%
|
9.07%
|
EPS
2 |
3.178
|
3.619
|
3.664
|
3.882
|
4.267
|
4.780
|
Free Cash Flow
1 |
-141.9
|
1,241
|
717.5
|
685.1
|
384.7
|
-84.71
|
FCF margin
|
-2.24%
|
19.21%
|
10.75%
|
10.42%
|
5.35%
|
-1.03%
|
FCF Conversion (EBITDA)
|
-
|
228.07%
|
116.41%
|
95.46%
|
51.89%
|
-
|
FCF Conversion (Net income)
|
-
|
241.03%
|
125.51%
|
112.84%
|
57.64%
|
-
|
Dividend per Share
2 |
2.721
|
2.993
|
3.175
|
3.175
|
3.476
|
3.800
|
Announcement Date
|
29/03/19
|
26/03/20
|
26/03/21
|
21/03/22
|
23/03/23
|
14/03/24
|
Fiscal Period: December |
2022 Q1
|
2022 Q2
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
---|
Net sales
1 |
1,708
|
1,674
|
2,006
|
2,022
|
2,020
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
165
|
143.7
|
-
|
179.4
|
156.3
|
Operating Margin
|
9.66%
|
8.58%
|
-
|
8.87%
|
7.74%
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
-
|
-
|
-
|
EPS
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
12/05/22
|
11/08/22
|
12/05/23
|
11/08/23
|
10/11/23
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
2,314
|
1,950
|
2,842
|
3,010
|
2,420
|
1,964
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-142
|
1,241
|
717
|
685
|
385
|
-84.7
|
ROE (net income / shareholders' equity)
|
6.7%
|
7.33%
|
7.35%
|
7.48%
|
7.84%
|
8.7%
|
ROA (Net income/ Total Assets)
|
1.89%
|
2.09%
|
2.38%
|
2.56%
|
2.4%
|
2.54%
|
Assets
1 |
23,857
|
24,624
|
24,005
|
23,762
|
27,805
|
29,371
|
Book Value Per Share
2 |
48.20
|
49.20
|
48.80
|
49.70
|
52.70
|
55.30
|
Cash Flow per Share
2 |
21.90
|
20.00
|
16.80
|
19.70
|
16.10
|
16.80
|
Capex
1 |
33
|
51.3
|
30.7
|
165
|
172
|
126
|
Capex / Sales
|
0.52%
|
0.79%
|
0.46%
|
2.51%
|
2.39%
|
1.53%
|
Announcement Date
|
29/03/19
|
26/03/20
|
26/03/21
|
21/03/22
|
23/03/23
|
14/03/24
|
|
1st Jan change
|
Capi.
|
---|
| +2.38% | 436M | | -3.88% | 9.36B | | +1.10% | 1.49B | | +2.65% | 1.43B | | -11.55% | 1.21B | | -16.13% | 877M | | +0.72% | 482M | | -47.14% | 374M | | -20.99% | 346M | | -2.34% | 213M |
Medical Equipment Wholesale
|